36216-80-5 | 1,2-Benzisoxazol-3-amine

Packsize	Purity	Availability	Price	Discounted Price
100mg	98%	in stock	$5.00	$4.00
250mg	98%	in stock	$9.00	$7.00
1g	98%	in stock	$11.00	$8.00
5g	98%	in stock	$54.00	$38.00
10g	98%	in stock	$99.00	$70.00
25g	98%	in stock	$220.00	$154.00

Description

• Catalog Number: AD39915
• Chemical Name: 1,2-Benzisoxazol-3-amine
• CAS Number: 36216-80-5
• Molecular Formula: C7H6N2O
• Molecular Weight: 134.1353
• MDL Number: MFCD03407353
• SMILES: Nc1noc2c1cccc2

Computed Properties

• Complexity: 129
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 10
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 1
• XLogP3: 1.4

Literature

• Study of the role of 'gatekeeper' mutations V654A and T670I of c-kit kinase in the interaction with inhibitors by means mixed molecular dynamics/docking approach.

  Bioinformation 20110101

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• Recent advances in the management of venous thromboembolism.

  The Korean journal of hematology 20100301

• Quantitative structure-activity relationship and classification analysis of diaryl ureas against vascular endothelial growth factor receptor-2 kinase using linear and non-linear models.

  Chemical biology & drug design 20090601

• Structure-activity relationship and pharmacokinetic profile of 5-ketopyrazole factor Xa inhibitors.

  Bioorganic & medicinal chemistry letters 20080115

• Preparation of 1-(3-aminobenzo[d]isoxazol-5-yl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective, and efficacious inhibitors of coagulation factor Xa.

  Bioorganic & medicinal chemistry letters 20061001

• Discovery of 1-(3'-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2'-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide hydrochloride (razaxaban), a highly potent, selective, and orally bioavailable factor Xa inhibitor.

  Journal of medicinal chemistry 20050324

• Structure-based design of novel guanidine/benzamidine mimics: potent and orally bioavailable factor Xa inhibitors as novel anticoagulants.

  Journal of medicinal chemistry 20031009

• Nonbenzamidine tetrazole derivatives as factor Xa inhibitors.

  Bioorganic & medicinal chemistry letters 20030210